Objective: To compare primary indications for cesarean delivery among patients with different female genital mutilation (FGM) status.
| INTRODUCTION
outcomes. 1 Evidence-based guidance to minimize the health consequences of FGM is essential for healthcare providers. 5 The impact of FGM on obstetric outcomes has been investigated. 2, [6] [7] [8] [9] [10] Compared with women without FGM, evidence suggests that women living with FGM have an increased risk of cesarean delivery, postpartum hemorrhage, episiotomy, extended maternal hospital admission, infant resuscitation, and inpatient perinatal death. 8, [11] [12] [13] The mechanisms of association between FGM and an increased risk for cesarean delivery are unknown, but it has been suggested that this is due to varying amounts of scar tissue. 2, 8 Scar tissue can restrict the vaginal opening but can also cause extensive vaginal and vulvar stenosis, resulting in differing degrees of obstructed labor. 2, 6, 8 Scarring can result from FGM itself, or from prior difficult deliveries.
FGM has been reported to be associated with difficult deliveries and fetal distress, which can also contribute to increased rates of cesarean delivery. 2, 14 It is also possible that FGM can limit the ability of providers to conduct pelvic exams to assess the safety and feasibility of alterna- 
| MATERIALS AND METHODS
The present study was a secondary analysis of a WHO multicenter prospective cohort study 8 Type IIc: Partial or total removal of the clitoris a , the labia minora, and the labia majora.
Type III: Narrowing of the vaginal orifice with creation of a covering seal by cutting and apposition the labia minora and/or the labia majora, with or without excision of the clitoris
Type IIIa: Removal and apposition of the labia minora.
Type IIIb: Removal and apposition of the labia majora.
Type IV: Unclassified
All other harmful procedures to the female genitalia for nonmedical purposes, for example, pricking, piercing, incising, scraping, and cauterization.
a When total removal of the clitoris is reported, it refers to the total removal of the glans of the clitoris.
Descriptive statistics and multinomial logistic regression were used to explore associations between FGM status and indications for cesarean delivery; the data were stratified by whether a clear medical indication for cesarean delivery was provided. Women with any type of FGM were compared with women without FGM using multivariable multinomial logistic regression stratified by whether or not the cesarean delivery was classified as medically necessary. Model covariates included parity, age, urban location, socioeconomic status, and education. Owing to the data being clustered in the six countries, robust standard errors were used to account for clustering. 18 Statistical analyses were conducted using Stata version 14 (Stata Corp LP, College
Station, TX, USA) and variables were compared using the χ 2 test and the Student t test, as appropriate.
| RESULTS
The present study included 1659 women, including 480 who had not undergone FGM, and 1179 who had any type of FGM (Table 1 ). There were a further three patients living with FGM who underwent cesarean delivery but cesarean-indication data were not available for these patients. The level of education and the country of residence differed significantly when stratified by FGM status.
The frequency of verbatim indications given by healthcare providers for cesarean deliveries, how these indications were classified, and whether these were classified as clear medical indications were collated ( Table 2 ). Indication data were missing for 3 (0.2%) patients. 
| DISCUSSION
Many studies have described increased cesarean delivery rates among women living with FGM; however, little evidence exists to explain the mechanisms that contribute to these increases. The findings of the present study suggest that among women with an unclear medical indication for cesarean delivery, women living with FGM are significantly more likely to have a cesarean delivery owing to a maternal factor or arrest disorder.
There were limitations to the present study that should be considered when interpreting the findings. The study did not include women who had scheduled cesarean deliveries, only those who had a trial of demonstrated that some women with FGM delay seeking medical attention until labor is well advanced out of a concern they will be forced to have a cesarean delivery. The present study did not control for the duration of pregnancy among patients who presented for prenatal care or the timing of defibulation, which could also impact the cesarean delivery rate.
T A B L E 2 (Continued) T A B L E 2 Indications for cesarean delivery.

Category of indication and specific indication for cesarean delivery
Cesarean delivery is a life-saving intervention for women and neonates when performed for medically indicated reasons. 21 However, it is a major surgery that can be associated with significant morbidity and even mortality. 22 The overall rate of cesarean delivery in the parent study population was low, 6%, 8 and was below the rate at which decreases in maternal and neonatal mortality rates are observed at the population level. 21, 23, 24 It is possible that even a low rate of elective or scheduled cesarean deliveries could explain these findings; this was a The elimination of FGM is a key focus of the sustainable development goal to achieve gender equality and empower for all women and girls. 25 Ending FGM will take a systematic and intense effort at multiple levels and it is essential that effective policies and interventions to eliminate FGM are identified and implemented. Equally important is the need for health evidence and training to minimize the negative health outcomes for girls and women living with FGM. 5 Scant data exist to guide the medical care of these patients. 5 Evidence is needed to guide the medical care of women living with FGM, in particular training for healthcare providers in the specific healthcare needs of this population. Data to help guide patients and healthcare providers in both accepting and offering defibulation could help mitigate the obstetric consequences of FGM.
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